Adams Respiratory Therapeutics Inc

Adams Respiratory Therapeutics — Q1 FY2008 Earnings Presentation

12 slides from Adams Respiratory Therapeutics's earnings presentation, Nov 8, 2007

  1. Slide 1: Fiscal 2008 First Quarter Earnings Results

    Fiscal 2008 First Quarter Earnings Results November 8, 2007

  2. Slide 2: Safe Harbor

    Safe Harbor This presentation contains certain "forward-looking" statements. These statements are based on the current estimates and assumptions of the management of Adams Respiratory Therapeutics, Inc. (or "Adams") as of the date of this presentation and are naturally subject to uncertainty and cha

  3. Slide 3: Strong Growth in Revenues

    12 - Months Ended 3 - Months Ended Strong Growth in Revenues (in millions) 6/03 9/06 6/04 6/05 CAGR '03-'07 120 % 9/07 6/06 $239.1 $110.0 $331.6 $90.1 6/07 +22% VYA % $14.0 $61.3 $160.2 $0.0 $50.0 $100.0 $150.0 $200.0 $250.0 $300.0 $350.0

  4. Slide 4: Fiscal 2008 First Quarter Net Sales by Product

    $45.5 $33.9 $10.1 $9.9 $7.3 $3.3 Fiscal 2008 First Quarter Net Sales by Product (in millions) $110.0 Total Net Sales Maximum Strength Mucinex(r) represented 23% of the total oral-solid adult Mucinex franchise sales

  5. Slide 5: Fiscal 2007/2008 Trade Inventory Analysis

    Fiscal 2007/2008 Trade Inventory Analysis (millions) Beginning Inventory Shipments Consumption Ending Inventory Q107 $ 70 (1) $ 90 $ (43) $ 117 Q207 117 111 (101) 127 Q307 127 84 (122) 89 Q407 89 47 (63) 73 FY07 70 332 (329) 73 (2) Q108 $ 73 $ 110 $ (51) $ 132 Estimated value of inventory in the tra

  6. Slide 6: First Quarter Earnings Reconciliation Chart

    First Quarter Earnings Reconciliation Chart 2007 2006 Growth 2007 2006 Growth 2007 2006 Growth Reported $46.2 $25.4 82% $29.2 $16.2 81% $0.79 $0.44 80% Mfg. Assets Repurchase Charge - - $9.7 - - $6.2 - - $0.17 Adjusted $46.2 $35.1 32% $29.2 $22.4 31% $0.79 $0.61 30% Net income Earnings per share Inc

  7. Slide 7: New Grape Delsym Achieves High Acceptance Levels

    New Grape Delsym(r) Achieves High Acceptance Levels Of the 115 customers we track: Over 90% accepted at least one SKU Over 65% accepted 2 SKUs

  8. Slide 8: Improved Retail Distribution

    Improved Retail Distribution Costco(r) Wholesale Stocking Mucinex SE Mucinex DM Delsym Pallet displays in top 200 stores

  9. Slide 9: 12-Hour Relief Center Display Support

    12-Hour Relief Center Display Support Visible at a major drug chain 5,000+ stores Starts early November for 9 weeks Pharmacy countertop Buy 2, Get $5.00 in Register Rewards

  10. Slide 10: Adams' Brands At Retail

    Adams' Brands At Retail

  11. Slide 11: Mucinex and Delsym Dollar Share Increases

    Mucinex and Delsym Dollar Share Increases Source: Information Resources, Inc. U.S. Food/Drug/Mass for the four weeks ended 10/7/07. 10.7 8.9 7.3 6.3 $ Share of Cough/Congestion Liquids Segment

  12. Slide 12: Fiscal 2008 First Quarter Earnings Results

    Fiscal 2008 First Quarter Earnings Results November 8, 2007

Adams Respiratory Therapeutics — Q1 FY2008 Earnings Presentation on 6ix